Amgen, Inc. (NASDAQ:AMGN)
| CAPS Rating |
|
|---|---|
| Open | $66.90 |
| Previous Close | $66.84 |
| Daily Range | $66.80 - $67.37 |
| 52-Week Range | $47.66 - $70.00 |
| Market Cap | $62.25B |
| P/E Ratio | 11.90 |
| Dividend (Yield) | 1.44 (N/A) |
| Volume | 5,221,911 |
| Average Daily Volume | 0 |
AMGN
VS S&P 500 (SPY)
How do you think AMGN will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
AMGN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
AMGN News and Commentary
- Buzz on the Street: Hurtling Through Chaos – Minyanville
- Ex-Dividend Stocks On February 13, 2012 – Blog at The Motley Fool
- 3 Biotechnology Stocks for Short-Term Traders – NASDAQ
- When Passing Your Clinical Trial Isn't Enough – The Motley Fool
- This Just In: More Upgrades and Downgrades – The Motley Fool
- How to Tell if Amgen Is Hiding Weakness – The Motley Fool
- Forget Big Pharma, It Is Time For A Biotech ETF - ETF News And Commentary – NASDAQ
- Zacks Bull and Bear of the Day Highlights: Amgen, Montpelier Re Holdings, Cisco Systems, Illumina an – NASDAQ
- Amgen, Inc. (AMGN) - Bull of the Day – NASDAQ
- Amgen Upped to Outperform - Analyst Blog – NASDAQ
- FDA Panel Votes Against Expanding Use Of Amgen Drug Xgeva – SmartMoney
- The Secret Reason Amgen's Earnings Are Awesome – The Motley Fool
- Can Amgen Convince Docs to Recommend Approval? – The Motley Fool
- WSJ BLOG/Health: FDA Questions Benefit of Amgen Bone Drug in Certain Cases – SmartMoney
- Amgen Cancer Drug Xgeva Faces Scrutiny for New Use – Minyanville
- FDA Questions Benefit Of Amgen Bone Drug In Certain Cases – SmartMoney
- This is NOT a tech bubble – CNN Money
- How Many Stocks Should You Own? - Investment Ideas – NASDAQ
- UPDATE: Pacific Rubiales Lists Depositary Receipts In Brazil – SmartMoney
- Amgen, Vivus, Chelsea Therapeutics Prep for Key Catalysts in February – Minyanville
RSS Headlines
Fool UK
